Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fungal cytochrome P450 enzymes (CYPs) are a large and diverse superfamily of heme-containing monooxygenases found throughout the fungal kingdom. These enzymes play essential roles in both primary and secondary metabolism, contributing to the biosynthesis of structural components, signaling molecules, detoxification of xenobiotics, and production of a wide array of secondary metabolites. Fungi possess more diverse CYP families than plants, animals, or bacteria. Many antifungal drugs target specific fungal P450 enzymes—most notably azole drugs inhibiting lanosterol 14α-demethylase (CYP51A), disrupting ergosterol synthesis essential for cell membrane integrity in fungi.
Inhibition of lanosterol 14α-demethylase (CYP51A) and disruption of ergosterol synthesis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fungal Cytochrome P450 Enzyme (CYP).